Increasing evidence has established causative links between obesity, chronic inflammation and insulin resistance; the core pathophysiological feature in type 2 diabetes mellitus. This study was designed to examine whether the combination of L-cysteine and metformin would provide additional benefits in reducing oxidative stress, inflammation and insulin resistance in streptozotocin-induced type 2 diabetes in rats. Male Wistar rats were fed a high-fat diet (HFD) for 8 weeks to induce insulin resistance, after which they were rendered diabetic with low-dose streptozotocin. Diabetic rats were treated with metformin (300 mg/kg/day), L-cysteine (300 mg/kg/day) and their combination along with HFD for another 2 weeks. Control rats were fed normal rat chow throughout the experiment. At the end of treatment, fasting blood glucose, fasting serum insulin, homeostasis model assessment–insulin resistance index (HOMA-IR) and serum free fatty acids (FFAs) were measured. Serum levels of the inflammatory markers; monocyte chemoattractant protein-1 (MCP-1), C-reactive protein (CRP) and nitrite/nitrate were also determined. The liver was isolated and used for determination of malondialdehyde (MDA), reduced glutathione (GSH), caspase-3 and cytochrome c levels. The hypoglycemic effect of the combination therapy exceeded that of metformin and L-cysteine monotherapies with more improvement in insulin resistance. All treated groups exhibited significant reductions in serum FFAs, oxidative stress and inflammatory parameters, caspase-3 and cytochrome c levels compared to untreated diabetic rats with the highest improvement observed in the combination group. In conclusion, the present results clearly suggest that L-cysteine can be strongly considered as an adjunct to metformin in management of type 2 diabetes.
Table of Contents
I. INTRODUCTION
II. AIM OF THE WORK
III. MATERIALS AND METHODS
IV. RESULTS
V. DISCUSSION
VI. CONCLUSIONS AND RECOMMENDATIONS
VII. SUMMARY
VIII. REFERENCES
Research Objective and Scope
The primary objective of this study is to evaluate the therapeutic potential of metformin and the antioxidant L-cysteine, both individually and in combination, in a rat model of streptozotocin-induced type 2 diabetes. The research focuses on assessing the impact of these treatments on metabolic regulation, inflammation, and oxidative stress pathways in the liver.
- Investigation of glycemic control and insulin resistance indices.
- Evaluation of lipid profile improvements, including triglycerides and cholesterol fractions.
- Assessment of inflammatory markers such as C-reactive protein (CRP) and monocyte chemoattractant protein-1 (MCP-1).
- Analysis of hepatic oxidative stress markers, including malondialdehyde and reduced glutathione.
- Histopathological examination of pancreatic tissue to observe structural changes and regenerative effects.
Excerpt from the Book
Cysteine and insulin resistance
An early study demonstrated that cysteine has an insulin-like action, promoting the entry of glucose into adipose cells, mediated by its free SH group. Cysteine has been subsequently shown to increase the levels of GLUT3 and GLUT4, with a marked enhancement of glucose uptake, in mouse muscle and human neuroblastoma cells (135). Moreover, Cysteine may improve glucose metabolism by preventing oxidative or nitrosative inhibition of the glycolytic enzymes glyceraldehyde-3-phosphate dehydrogenase and glucose-6- phosphate dehydrogenase (115).
In cultured adipocytes, it was demonstrated that cysteine supplementation reverses the increased intracellular oxidative stress, after AGE-RAGE interaction, which causes a decrease in glucose uptake (136) and also prevents the methylglyoxal induced decrease in IRS-1 tyrosine phosphorylation and PI3K activity that impair insulin signaling (137). This is illustrated in Figure (10).
It was also reported that cysteine analogues potentiate the glucose-induced insulin release in pancreatic islets isolated from female Wistar rats(138). Dietary intake of whey protein and α-lactoalbumin (cysteine-rich proteins) lowers the oxidative stress and insulin resistance induced by sucrose in rats (139). Other studies have reported that N-acetylcysteine supplementation reduces fructose-induced insulin resistance in rats (140) and also improves insulin sensitivity in women with polycystic ovaries (141).
Chapter Summary
I. INTRODUCTION: This chapter outlines the epidemiology, classification, and pathophysiology of diabetes mellitus, focusing on oxidative stress, inflammation, and current pharmacological management strategies.
II. AIM OF THE WORK: This section defines the study's goal to assess the impact of metformin and L-cysteine on diabetic rats.
III. MATERIALS AND METHODS: This chapter details the animal models, drug dosages, experimental groups, and biochemical methodologies used for the analysis.
IV. RESULTS: This chapter presents findings on the biochemical parameters, lipid profiles, oxidative stress markers, and histopathological changes observed across the treatment groups.
V. DISCUSSION: This chapter interprets the experimental results, examining how the treatments affected metabolic and inflammatory pathways compared to existing literature.
VI. CONCLUSIONS AND RECOMMENDATIONS: This section summarizes the therapeutic benefits of the combination treatment and offers suggestions for future clinical research.
VII. SUMMARY: This chapter provides a condensed overview of the research, confirming the synergistic efficacy of the metformin and L-cysteine combination.
Keywords
Diabetes mellitus, Type 2 diabetes, Metformin, L-cysteine, Insulin resistance, Oxidative stress, Lipid profile, Inflammation, C-reactive protein, MCP-1, Glutathione, Malondialdehyde, Streptozotocin, Rat model, Adjuvant therapy
Frequently Asked Questions
What is the core focus of this research?
The research examines the therapeutic efficacy of metformin and the antioxidant amino acid L-cysteine, used separately and in combination, to manage type 2 diabetes mellitus in a rat model.
What are the primary themes of the study?
The key themes include the management of hyperglycemia, the improvement of lipid profiles, the mitigation of oxidative stress, and the reduction of inflammatory markers in diabetic subjects.
What is the research question addressed by the authors?
The study asks whether a combined therapy of metformin and L-cysteine can offer superior benefits in improving glycemic control and reducing diabetes-associated oxidative stress compared to monotherapy.
Which scientific methods were employed?
The researchers utilized an experimental rat model induced by high-fat diet and streptozotocin, followed by blood biochemical assays, ELISA for inflammatory markers, and histopathological analysis of pancreatic tissue.
What topics are discussed in the main body?
The main body covers the pathophysiology of diabetes, the role of oxidative stress in disease progression, pharmacological properties of metformin and L-cysteine, and detailed experimental results from treated groups.
Which keywords best characterize this work?
The work is characterized by terms such as Type 2 diabetes, metformin, L-cysteine, insulin resistance, oxidative stress, and anti-inflammatory effects.
Why is L-cysteine combined with metformin in this experiment?
L-cysteine acts as a precursor to glutathione, an essential antioxidant. The study explores whether adding this antioxidant can synergistically improve the metabolic and anti-inflammatory outcomes beyond what metformin achieves alone.
What was the observed effect on pancreatic tissue?
Histopathological examination showed that combination therapy with metformin and L-cysteine resulted in better-formed regenerating islets compared to the untreated diabetic group, indicating enhanced protection against damage.
- Citar trabajo
- Mennatallah Ali (Autor), 2012, New Prespectives for Type 2 Diabetes Management, Múnich, GRIN Verlag, https://www.grin.com/document/272379
